UNSPSC 85891408: Low dose rate (ldr) brachytherapy of bone marrow using palladium 103 (pd-103)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of low dose rate (ldr) brachytherapy of bone marrow using palladium 103 (pd-103). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D710BBZ

UNSPSC 85891408 Low dose rate (ldr) brachytherapy of bone marrow using palladium 103 (pd-103) is a Commodity code with no recent state and local contract opportunities in the source data that match its nominal scope. The single recent posting under this code—Santa Clara County Health System's RFQ for temporary health professional staffing services (RFSQHHSF270052, due October 7, 2026)—is unrelated to brachytherapy, bone marrow treatment, or palladium-103 applications. The solicitation covers ancillary clinical staffing across audiology, cardiology, diagnostic imaging, gastroenterology, orthopedic, respiratory care, sterile processing, surgical, and therapy services, with no oncology or radiation-treatment components present.

The mismatch between the code's stated clinical scope and the actual procurement activity suggests either a coding error in the state or local opportunity posting or that this Commodity code does not see active use in current state and local procurement. Without additional opportunities in the source data, no issuing-body pattern, geographic concentration, or representative procurement pipeline can be characterized. Firms pursuing radiation oncology, brachytherapy equipment, or isotope-based medical services should verify code assignments directly with health system procurement offices rather than rely on current UNSPSC tagging in public databases for this category.